Using CPAP to treat sleep apnea could help improve cognitive decline symptoms in older adults with mild cognitive impairment.
Researchers have identified a mechanism that occurs within the CA3 region of the hippocampus that appears to be responsible for a common type of age-related memory loss.
A new study reports that increased volume in the choroid plexus appears to be associated with greater cognitive impairment and Alzheimer's disease.
Sleep continuity, in addition to sleep quality, can determine how a person with dementia will experience their symptoms the next day.
A combination of patient-reported subjective cognitive impairment and measurable clinical symptoms, such as amyloid-beta accumulation in the cerebrospinal fluid, may help in the early diagnosis of Alzheimer's disease.
Healthy eating, daily exercise, reducing alcohol consumption, and not smoking not only lead to a longer life, but they can also reduce Alzheimer's risk for those with genetic risk factors.
Middle-aged people who consume blueberries every day may have a reduced risk of developing dementia, a new study reports.
Researchers have developed a set of tests that can quantify cognitive changes in aging dogs and accurately detect canine cognitive dysfunction syndrome, a disorder with similar pathology and outcomes as Alzheimer's disease in humans. The findings show promise for both humans and dogs in understanding Alzheimer's progression.
Elevated levels of PHGDH in the blood could signal the earliest stages of Alzheimer's disease. Researchers caution older adults against using "brain-boosting" supplements that contain serine due to its link to PHGDH. As PHGDH is a key enzyme in serine production, elevated PHGDH levels results in increased serine levels in the brain.
The corn-derived MetO-rich protein, when injected, prompts the immune system to produce antibodies against the MetO component of amyloid beta. Older mice injected with the MetO-rich protein showed 50% improvement in memory compared to the control animals. The findings could be key to the development of a potential vaccine for Alzheimer's.
People with higher levels of the antioxidants lutein, zeaxanthin, and beta-cryptoxanthin may have a lower risk of developing dementia, researchers report.